Details for New Drug Application (NDA): 201865
✉ Email this page to a colleague
The generic ingredient in LORATADINE is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.
Summary for 201865
Tradename: | LORATADINE |
Applicant: | Taro |
Ingredient: | loratadine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 201865
Suppliers and Packaging for NDA: 201865
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LORATADINE | loratadine | SYRUP;ORAL | 201865 | ANDA | WALGREEN COMPANY | 0363-0771 | 0363-0771-01 | 1 BOTTLE in 1 CARTON (0363-0771-01) / 240 mL in 1 BOTTLE |
LORATADINE | loratadine | SYRUP;ORAL | 201865 | ANDA | WALGREEN COMPANY | 0363-0771 | 0363-0771-08 | 1 BOTTLE in 1 CARTON (0363-0771-08) / 120 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | SYRUP;ORAL | Strength | 1MG/ML | ||||
Approval Date: | Jul 31, 2015 | TE: | RLD: | No |
Complete Access Available with Subscription